Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer

Cancer Med. 2020 Oct;9(19):6909-6922. doi: 10.1002/cam4.3379. Epub 2020 Aug 10.

Abstract

More and more studies report that exosomes released by various cells can serve as a medium for information exchange between different cells. Through a deep understanding of the physical and chemical properties of exosomes, the researchers revealed a more precise molecular mechanism of its participation in the process of intercellular communication. In particular, microRNA (miRNA) is found inside exosomes, as well as long noncoding RNA (lncRNA). Extensive evidence indicates that exosomal miRNAs participates in the occurrence and development of lung cancer and plays a variety of roles. Therefore, the release of RNA-containing exosomes in many different kinds of body fluids has caused widespread interest among researchers. In this review, we report evidence from human studies involving miRNAs and other ncRNAs in exosomes associated with lung cancer as diagnostic and prognostic markers. Currently, there is a small amount of evidence that exosomal miRNAs can be used as early diagnosis and prognostic markers for lung cancer, and their exact role in lung cancer patients still needs further study.

Keywords: biomarker; diagnostic; exosomal miRNA; lung cancer; non-coding RNA; prognostic.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Exosomes / genetics*
  • Exosomes / metabolism
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / therapy
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Molecular Diagnostic Techniques
  • Predictive Value of Tests
  • Prognosis

Substances

  • Biomarkers, Tumor
  • MicroRNAs